Inoculation of QuantiFERON-TB tubes with skin microbiota causes false-positive results

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 7, 2014, Pages 834-837

  Gaur, Rajiv L ^a   Banaei, Niaz ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT;

ADAPTIVE IMMUNITY; BLOOD VOLUME; CLINICAL LABORATORY; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FALSE POSITIVE RESULT; HEALTH CARE PERSONNEL; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LETTER; LOW RISK POPULATION; MYCOBACTERIUM TUBERCULOSIS TEST KIT; PHLEBOTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SKIN FLORA; STAPHYLOCOCCUS AUREUS; TUBERCULOSIS; VEIN PUNCTURE; WILCOXON SIGNED RANKS TEST; IMMUNOLOGY; LABORATORY DIAGNOSIS; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; SKIN;

FALSE POSITIVE REACTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MICROBIOTA; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SKIN; TUBERCULOSIS;

EID: 84925359092     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201406-1041LE     Document Type: Letter

References (10)

1. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59: 1-25.
2. Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, Metcalfe JZ, Cattamanchi A, Dowdy DW, Dheda K, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 2014;27:3-20.
3. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, et al.; Tuberculosis Epidemiologic Studies Consortium. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 2014;189:77-87.
4. Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors in fluencing prognosis. Rev Infect Dis 1983;5:54-70.
5. Hall KK, Lyman JA. Updated review of blood culture contamination. Clin Microbiol Rev 2006;19:788-802.
6. Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009;22:240-273. (Table of Contents.).
7. Gaur RL, Suhosk MM, Banaei N. In vitro immunomodulation of a whole blood IFN-γ release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS ONE 2012;7:e48027.
8. Huang SJ, Hijnen D, Murphy GF, Kupper TS, Calarese AW, Mollet IG, Schanbacher CF, Miller DM, Schmults CD, Clark RA. Imiquimod enhances IFN-γ production and effector function of T cells infiltrating human squamous cell carcinomas of the skin. J Invest Dermatol 2009; 129:2676-2685.
9. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol 2011;9: 244-253.
10. Schifman RB, Strand CL, Meier FA, Howanitz PJ. Blood culture contamination: a College of American Pathologists Q-Probes study involving 640 institutions and 497134 specimens from adult patients. Arch Pathol Lab Med 1998;122:216-221.